413 related articles for article (PubMed ID: 17130878)
1. Post-ERCP pancreatitis and its prevention.
Frank CD; Adler DG
Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):680-8. PubMed ID: 17130878
[TBL] [Abstract][Full Text] [Related]
2. Preventing post-ERCP pancreatitis: where are we?
Testoni PA
JOP; 2003 Jan; 4(1):22-32. PubMed ID: 12555013
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis.
Madácsy L; Kurucsai G; Fejes R; Székely A; Székely I
Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794
[TBL] [Abstract][Full Text] [Related]
4. Post-ERCP pancreatitis: review of current preventive strategies.
Feurer ME; Adler DG
Curr Opin Gastroenterol; 2012 May; 28(3):280-6. PubMed ID: 22450899
[TBL] [Abstract][Full Text] [Related]
5. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
Choi CW; Kang DH; Kim GH; Eum JS; Lee SM; Song GA; Kim DU; Kim ID; Cho M
Gastrointest Endosc; 2009 Apr; 69(4):e11-8. PubMed ID: 19327467
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis.
Bailey AA; Bourke MJ; Williams SJ; Walsh PR; Murray MA; Lee EY; Kwan V; Lynch PM
Endoscopy; 2008 Apr; 40(4):296-301. PubMed ID: 18389448
[TBL] [Abstract][Full Text] [Related]
7. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis.
Dumonceau JM; Andriulli A; Deviere J; Mariani A; Rigaux J; Baron TH; Testoni PA;
Endoscopy; 2010 Jun; 42(6):503-15. PubMed ID: 20506068
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study.
Lee TH; Moon JH; Choi HJ; Han SH; Cheon YK; Cho YD; Park SH; Kim SJ
Gastrointest Endosc; 2012 Sep; 76(3):578-85. PubMed ID: 22771100
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic retrograde cholangiopancreatography (ERCP)-related adverse events: post-ERCP pancreatitis.
Rustagi T; Jamidar PA
Gastrointest Endosc Clin N Am; 2015 Jan; 25(1):107-21. PubMed ID: 25442962
[TBL] [Abstract][Full Text] [Related]
11. Indomethacin for post-ERCP pancreatitis prophylaxis: another attempt at the Holy Grail.
Wagh MS; Sherman S
Am J Gastroenterol; 2007 May; 102(5):984-6. PubMed ID: 17489783
[TBL] [Abstract][Full Text] [Related]
12. Clinical study on the prevention of post-ERCP pancreatitis by pancreatic duct stenting.
Pan XP; Dang T; Meng XM; Xue KC; Chang ZH; Zhang YP
Cell Biochem Biophys; 2011 Dec; 61(3):473-9. PubMed ID: 21739262
[TBL] [Abstract][Full Text] [Related]
13. Risk for post-ERCP pancreatitis after needle knife precut sphincterotomy following repeated cannulation attempts.
Lee JK; Park JK; Yoon WJ; Lee SH; Lee KH; Ryu JK; Kim YT; Yoon YB
J Clin Gastroenterol; 2007 Apr; 41(4):427-31. PubMed ID: 17413615
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy for the prevention of post-ERCP pancreatitis.
Foster E; Leung J
Am J Gastroenterol; 2007 Jan; 102(1):52-5. PubMed ID: 17266688
[TBL] [Abstract][Full Text] [Related]
15. Incidence, risk factors, and prevention of post-ERCP pancreatitis.
Cooper ST; Slivka A
Gastroenterol Clin North Am; 2007 Jun; 36(2):259-76, vii-viii. PubMed ID: 17533078
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis.
Zheng M; Chen Y; Bai J; Xin Y; Pan X; Zhao L
Pancreas; 2008 Oct; 37(3):247-53. PubMed ID: 18815544
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients.
Sofuni A; Maguchi H; Mukai T; Kawakami H; Irisawa A; Kubota K; Okaniwa S; Kikuyama M; Kutsumi H; Hanada K; Ueki T; Itoi T
Clin Gastroenterol Hepatol; 2011 Oct; 9(10):851-8; quiz e110. PubMed ID: 21749851
[TBL] [Abstract][Full Text] [Related]
18. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
Zheng M; Chen Y; Yang X; Li J; Zhang Y; Zeng Q
BMC Gastroenterol; 2007 Feb; 7():6. PubMed ID: 17295917
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks.
Andriulli A; Forlano R; Napolitano G; Conoscitore P; Caruso N; Pilotto A; Di Sebastiano PL; Leandro G
Digestion; 2007; 75(2-3):156-63. PubMed ID: 17684365
[TBL] [Abstract][Full Text] [Related]
20. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis.
Kaffes AJ; Bourke MJ; Ding S; Alrubaie A; Kwan V; Williams SJ
Gastrointest Endosc; 2006 Sep; 64(3):351-7. PubMed ID: 16923481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
